Clara reads the full weight-management label against your chart before any GLP-1 is drafted. Free to connect your records.
Get started How it worksClara auto-syncs your records from 150,000+ doctors' offices, hospitals, clinics, labs, and wearables. Before anything is prescribed, the AI reads your BMI, comorbidity list, pregnancy status, thyroid and pancreatitis history, and medication list against the Wegovy label. Free to start, no credit card.
If Wegovy is clinically appropriate, a licensed physician reviews Clara's plan and signs the prescription. It's sent to your pharmacy and may be covered by your insurance, unlike the cash-pay compounded semaglutide DTC brands ship from a mail-order 503A pharmacy.
Wegovy titrates 0.25 → 0.5 → 1 → 1.7 → 2.4 mg weekly over 16 weeks3. Clara watches your GI tolerability, weight trend, and wearable resting HR to pace each step-up correctly. Slow the titration if nausea is significant; skip a step if your system isn't ready.
See whether your chart is on-label for Wegovy before you pay for a thing.
Get started Free to connect your records. No credit card to start.Titration dose only, not effective for weight management on its own. The point is to introduce the molecule gently so your gastrointestinal system adapts before meaningful exposure.
Monthly step-ups. Clara reads nausea frequency, early-satiety reports, and any weight-trend reversal before advancing. If you're not tolerating a step, Clara recommends holding the prior dose longer rather than forcing through.
The target maintenance dose at week 16 and beyond. This is the dose studied in the pivotal STEP trials for chronic weight management3. Clara monitors your weight trajectory and reorders labs at 3 months.
Dual GIP/GLP-1 agonist. If Wegovy is ineffective or poorly tolerated, Clara flags Zepbound as the alternative on-label weight-management GLP-1. Zepbound also carries an FDA indication for moderate-to-severe obstructive sleep apnea in adults with obesity4.
| Clara | Hims & Hers | Lemonaid Health | Your doctor | |
|---|---|---|---|---|
| 24/7 AI clinical chat | ✓ Unlimited | Async Care Team messaging | Async provider messaging | ✗ |
| Checks the Wegovy label against your full chart | ✓ Every prescription | Single-condition intake | Per-category intake | Depends on visit length |
| Cost to start chatting | Free | $39 first-month membership | Brief eligibility assessment | $150+ copay per visit |
| Membership cost | From $25/mo cash-pay (HSA/FSA eligible); medication billed separately, may be covered by your insurance | $149/mo after first month; medication bundled, cash-pay | $49/mo; medication billed separately, cash-pay | Per-visit copay |
| Branded FDA-approved Wegovy | ✓ | Wegovy Pen from $199/mo cash on top of membership; Wegovy Pill from $149/mo | Sold alongside compounded semaglutide, cash-pay | ✓ |
| Prescription may be covered by your insurance | ✓ | ✗ | ✗ | ✓ |
| Cross-condition reasoning (BP, thyroid, lipids, pregnancy plans) | ✓ | Single-condition | Per-intake siloes | In theory, rarely in 15 minutes |
| Full primary care, not just weight loss | ✓ | Single-category | Partial, separate intakes | ✓ |
| Labs and biomarkers included in membership | Up to 108 on Concierge | Extra cost | Extra cost | Copay per test |
DTC brands ship compounded semaglutide cash-pay. Clara writes branded FDA-approved Wegovy.
Get started Your prescription may be covered by your insurance. HSA/FSA eligible.The same semaglutide is sold as Ozempic (type 2 diabetes) and as Wegovy (chronic weight management). The label difference is not cosmetic: it determines whether your insurance will cover the script, whether the 2.4 mg dose is on-label, and whether the pediatric indication applies. Clara reads the label carefully, not just the drug name.
If weight is your primary indication and you're not diabetic, Clara writes Wegovy, not Ozempic. Beyond safety, this is what insurance formularies look for: the product prescribed on-label for the indication.
Clara watches GI side effects, early satiety, and wearable resting HR through each step-up. Patients who rush to 2.4 mg too fast tend to drop out for nausea. Slower is often better; Clara reads the trend and advises holding when it should.
Clara can cite the specific STEP-1 outcome table, the STEP-3 lifestyle-intervention figures, or the STEP-TEENS pediatric data behind any recommendation it makes. A generalist physician likely last read this literature years ago, if at all.
An AI that reads every STEP trial and every weight-trend datapoint on your chart in one pass.
Get started 150,000+ sources synced automatically. Cancel anytime.Start free. Connect your records. See what happens when an AI reads the Wegovy label against your whole chart.
Get started